The present technology relates to placebo compositions and their use in clinical trials for oral immunotherapy of peanut allergies. Therapy can be treatment or desensitization of peanut allergies. The placebo formulation is used as a control compared to an active ingredient formulation. Further, the present technology relates to methods for the preparation of the placebo compositions.